U.S. Markets close in 1 hr 1 min

Aratana Therapeutics, Inc. (PETX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.26+0.01 (+0.14%)
As of 2:55PM EDT. Market open.
People also watch
OMEROMEDPTCTOCULKPTI
Full screen
Previous Close7.25
Open7.49
Bid7.27 x 100
Ask7.29 x 400
Day's Range7.20 - 7.49
52 Week Range4.97 - 10.73
Volume168,519
Avg. Volume358,090
Market Cap305.43M
Beta3.13
PE Ratio (TTM)-9.24
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals9 minutes ago

    Aratana sniffs out new use for dog drug in cats

    Aratana Therapeutics reported positive results from a trial in a local anesthetic for man’s best friend tested in felines. It's the second trial the Leawood-based animal health company had conducted on the treatment, currently marketed for dogs as Nocita. The treatment was based on an existing local anesthetic approved for humans, Exparel, which releases a local anesthetic from liposomes deposited in the tissue.

  • Capital Cube19 days ago

    ETFs with exposure to Aratana Therapeutics, Inc. : July 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aratana Therapeutics, Inc. Here are 5 ETFs with the largest exposure to PETX-US. Comparing the performance and risk of Aratana Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Aratana Therapeutics, Inc. : June 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aratana Therapeutics, Inc. Here are 5 ETFs with the largest exposure to PETX-US. Comparing the performance and risk of Aratana Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)